Virtus LifeSci Biotech Clinical Trials ETF
10 hedge funds and large institutions have $8.57M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$6.57M | |
2 | +$624K | |
3 | +$469K | |
4 |
BAAM
Baker Avenue Asset Management
San Francisco,
California
|
+$267K |
5 |
Jane Street
New York
|
+$146K |